|
LC992a : Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/99 cores, replacing LC992
Description
| Microarray Panel |
Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue microarray, containing 25 cases of invasive adenocarcinoma, 2 invasive acinar adenocarcinoma, 3 papillary adenocarcinoma, 3 mucinous adenocarcinoma, and matched cancer adjacent lung tissue and adjacent normal lung tissue, triplicated cores per case |
| Cores |
99 |
|
| Cases |
33 |
| Row number |
11 |
| Column number |
9 |
| Core Diameter (mm) |
1 |
| Thickness (µm) |
5 |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: LC992a
- Availability: In Stock
|
Tags:
With normal control,
With adjacent normal,
Stage (TNM),
Triplicate cores per case
- AT,
- Malignant tumor (stage IA),
- Malignant tumor (stage IA2),
- Malignant tumor (stage IA3),
- Malignant tumor (stage IB),
- Malignant tumor (stage IIA),
- Malignant tumor (stage IIB),
- Malignant tumor (stage IIIA),
- Malignant tumor (stage IIIB),
- NAT